A Multicenter, Randomized, Placebo Controlled, Double-blind, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Invossa K Injection in Patients Diagnosed as Knee Osteoarthritis With Kellgren & Lawrence Grade 2
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Mar 2018
At a glance
- Drugs Tonogenchoncel-L (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Sponsors Kolon Life Science
- 31 Aug 2018 Biomarkers information updated
- 05 Mar 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 19 Dec 2017 Status changed from planning to not yet recruiting.